Gershon PD - Search Results

1

Synthesis and application of a chain-terminating dinucleotide mRNA cap analog.

Peng ZH, Sharma V, Singleton SF, Gershon PD. Peng ZH, et al. Among authors: gershon pd. Org Lett. 2002 Jan 24;4(2):161-4. doi: 10.1021/ol0167715. Org Lett. 2002. PMID: 11796040

2

The "cap-binding slot" of an mRNA cap-binding protein: quantitative effects of aromatic side chain choice in the double-stacking sandwich with cap.

Hu G, Oguro A, Li C, Gershon PD, Quiocho FA. Hu G, et al. Among authors: gershon pd. Biochemistry. 2002 Jun 18;41(24):7677-87. doi: 10.1021/bi0201926. Biochemistry. 2002. PMID: 12056899

3

Recognition of capped RNA substrates by VP39, the vaccinia virus-encoded mRNA cap-specific 2'-O-methyltransferase.

Lockless SW, Cheng HT, Hodel AE, Quiocho FA, Gershon PD. Lockless SW, et al. Among authors: gershon pd. Biochemistry. 1998 Jun 9;37(23):8564-74. doi: 10.1021/bi980178m. Biochemistry. 1998. PMID: 9622508

4

Structural basis for sequence-nonspecific recognition of 5'-capped mRNA by a cap-modifying enzyme.

Hodel AE, Gershon PD, Quiocho FA. Hodel AE, et al. Among authors: gershon pd. Mol Cell. 1998 Feb;1(3):443-7. doi: 10.1016/s1097-2765(00)80044-1. Mol Cell. 1998. PMID: 9660928 Free article.

5

The surface region of the bifunctional vaccinia RNA modifying protein VP39 that interfaces with Poly(A) polymerase is remote from the RNA binding cleft used for its mRNA 5' cap methylation function.

Shi X, Bernhardt TG, Wang SM, Gershon PD. Shi X, et al. Among authors: gershon pd. J Biol Chem. 1997 Sep 12;272(37):23292-302. doi: 10.1074/jbc.272.37.23292. J Biol Chem. 1997. PMID: 9287339 Free article.

6

Use of vaccinia virus poly(A) polymerase for RNA 3'-end labeling with a chain-terminating nucleotide or a short 3' homopolymer tract.

Thomson JG, Gershon PD. Thomson JG, et al. Among authors: gershon pd. Biotechniques. 1995 Sep;19(3):416-20, 422-5. Biotechniques. 1995. PMID: 7495555

7

Methyltransferase-specific domains within VP-39, a bifunctional protein that participates in the modification of both mRNA ends.

Shi X, Yao P, Jose T, Gershon P. Shi X, et al. RNA. 1996 Jan;2(1):88-101. RNA. 1996. PMID: 8846300 Free PMC article.

The nature of the methyltransferase defects in 10 of the methyltransferase-specific defectives, identified both herein and in a previous study (Schnierle BS, Gershon PD, Moss B, 1994, J biol Chem 269:20700-20706), was investigated using two novel substrate-binding a …

The nature of the methyltransferase defects in 10 of the methyltransferase-specific defectives, identified both herein and in a previous stu …

8

A polyadenylylation-specific RNA-contact site on the surface of the bifunctional vaccinia virus RNA modifying protein VP39 that is distinct from the mRNA 5' end-binding "cleft".

Deng L, Johnson L, Neveu JM, Hardin S, Wang SM, Lane WS, Gershon PD. Deng L, et al. Among authors: gershon pd. J Mol Biol. 1999 Jan 29;285(4):1417-27. doi: 10.1006/jmbi.1998.2417. J Mol Biol. 1999. PMID: 9917386

9

The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends.

Hodel AE, Gershon PD, Shi X, Quiocho FA. Hodel AE, et al. Among authors: gershon pd. Cell. 1996 Apr 19;85(2):247-56. doi: 10.1016/s0092-8674(00)81101-0. Cell. 1996. PMID: 8612277 Free article.

10

Mechanism of RNA 2'-O-methylation: evidence that the catalytic lysine acts to steer rather than deprotonate the target nucleophile.

Li C, Xia Y, Gao X, Gershon PD. Li C, et al. Among authors: gershon pd. Biochemistry. 2004 May 18;43(19):5680-7. doi: 10.1021/bi0359980. Biochemistry. 2004. PMID: 15134442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page